Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: manny t who wrote (7489)	4/22/1999 3:23:00 PM
From: Nick	Respond to of 9523

Here's more info: Pfizer Inc Announces Three-For-One Stock Split; Board of Directors Declares 22-Cent Per Share Dividend NEW YORK, April 22 /PRNewswire/ -- Pfizer Inc today announced that its Board of Directors has declared a three-for-one split of the company's common stock in the form of a 200-percent stock dividend to shareholders of record on June 2, 1999, and payable June 30, 1999. The decision followed a vote by shareholders to increase the number of authorized common shares to 9 billion. The company also announced a 22-cents per share second-quarter cash dividend on a pre-split basis. The cash dividend is payable June 10, 1999, to shareholders of record on May 7, 1999, and is the 242nd consecutive quarterly dividend paid by Pfizer. This will be the ninth split of Pfizer common stock since it was first publicly traded in 1942. As a result of the split, the number of shares outstanding will triple to approximately 3.78 billion. Pfizer Inc is a research-based global pharmaceutical company that discovers, develops, manufactures and markets innovative medicines for humans and animals. The company reported revenues of more than $13.5 billion in 1998 and spent more than $2.2 billion on research and development. In 1999, Pfizer celebrates its 150th anniversary.